Synthesis of acylguanidine zanamivir derivatives as neuraminidase inhibitors and the evaluation of their bio-activities†
Abstract
A series of acylguanidine-modified
* Corresponding authors
a Department of Chemistry, National Tsing Hua University, 101, Section 2, Kuang-Fu Road, Hsinchu 30013, Taiwan
b Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes, 35, Keyan Road, Zhunan 35053, Taiwan
c Department of Biological Science and Technology and Applied Chemistry Department, National Chiao Tung University, University Road, Hsinchu 30010, Taiwan
d
Institute for Glycomics, Griffith University (Gold Coast Campus), Southport, Queensland 4222, Australia
E-mail:
cclin66@mx.nthu.edu.tw
Fax: +886 3-571-1082
A series of acylguanidine-modified
C. Lin, T. Chang, A. Das, M. Fang, H. Hung, K. Hsu, J. Yang, M. von Itzstein, K. K. T. Mong, T. Hsu and C. Lin, Org. Biomol. Chem., 2013, 11, 3943 DOI: 10.1039/C3OB40624E
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.
Fetching data from CrossRef.
This may take some time to load.
Loading related content